Helping protect people from life-threatening illnesses
We help protect as many people as possible from life-threatening illness with quality vaccines that make an impact across all stages of life.(1)
In India, as of 2010, pneumococcal disease took the life of 1 child every 2 minutes.(2) According to a study, there were an estimated 0.56 million severe episodes of pneumococcal disease annually and 105,000 pneumococcal deaths in children under 5 years(2). Pneumococcal disease is a major public health concern for older adults as well, particularly those with chronic conditions such as heart disease, respiratory disease and elevated blood sugar levels. (3)
For over 20 years, Pfizer has been helping protect as many people as possible from one of the world’s most pernicious vaccine-preventable illnesses: pneumococcal disease, which includes lung, ear and brain infections. (4)
Passion drives us
Our passion for science, for delivering excellence and for people’s health drives bold advancements in Research and Design (R&D) and high-quality manufacturing to consistently make a meaningful impact on public health. Passion drives our organization and permeates everything we do.
We also carry out education programs for health care professionals as per recommendations of the Indian societies. Using digital channels and social media we reach out to millions to address common concerns and promote the well-being of all age groups.
Via multiple access and awareness initiatives for healthcare professionals and paramedics in pediatric and elderly settings, we continue to drive scientific conversations and share latest updates on vaccines.
Every day, we work toward a healthier world by inventing, developing and championing vaccines, which provide essential health benefits to people of all ages.
This information—including product information—is intended only for residents of India. The products discussed herein may have different labelling in different countries. Patients should always ask their doctors for medical advice.
PP-CPF-IND-0035 | 11/11/21
Inflammation and Immunology